State Street’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-108,451
| Closed | -$12.8M | – | 4543 |
|
|
2021
Q1 | $12.8M | Buy |
108,451
+37,399
| +53% | +$4.42M | ﹤0.01% | 2616 |
|
|
2020
Q4 | $8.39M | Buy |
71,052
+8,593
| +14% | +$998K | ﹤0.01% | 2724 |
|
|
2020
Q3 | $6.94M | Buy |
62,459
+1,945
| +3% | +$209K | ﹤0.01% | 2638 |
|
|
2020
Q2 | $6.18M | Buy |
60,514
+5,302
| +10% | +$567K | ﹤0.01% | 2653 |
|
|
2020
Q1 | $5.96M | Sell |
55,212
-2,354
| -4% | -$270K | ﹤0.01% | 2546 |
|
|
2019
Q4 | $6.7M | Buy |
57,566
+3,560
| +7% | +$412K | ﹤0.01% | 2706 |
|
|
2019
Q3 | $6.18M | Buy |
54,006
+19,029
| +54% | +$1.89M | ﹤0.01% | 2679 |
|
|
2019
Q2 | $3.33M | Sell |
34,977
-1,976
| -5% | -$186K | ﹤0.01% | 3029 |
|
|
2019
Q1 | $3.37M | Buy |
36,953
+9,556
| +35% | +$782K | ﹤0.01% | 2939 |
|
|
2018
Q4 | $2.08M | Buy |
27,397
+1,248
| +5% | +$91.8K | ﹤0.01% | 3108 |
|
|
2018
Q3 | $2.09M | Buy |
26,149
+6,079
| +30% | +$566K | ﹤0.01% | 3228 |
|
|
2018
Q2 | $1.99M | Buy |
20,070
+102
| +0.5% | +$8.81K | ﹤0.01% | 3260 |
|
|
2018
Q1 | $1.62M | Buy |
19,968
+4,475
| +29% | +$362K | ﹤0.01% | 3233 |
|
|
2017
Q4 | $1.22M | Buy |
15,493
+1,469
| +10% | +$122K | ﹤0.01% | 3315 |
|
|
2017
Q3 | $1.29M | Buy |
14,024
+1,606
| +13% | +$154K | ﹤0.01% | 3326 |
|
|
2017
Q2 | $1.4M | Sell |
12,418
-1,919
| -13% | -$214K | ﹤0.01% | 3258 |
|
|
2017
Q1 | $1.44M | Buy |
14,337
+1,541
| +12% | +$165K | ﹤0.01% | 3195 |
|
|
2016
Q4 | $1.38M | Buy |
12,796
+768
| +6% | +$89.8K | ﹤0.01% | 3215 |
|
|
2016
Q3 | $1.5M | Buy |
12,028
+1,324
| +12% | +$156K | ﹤0.01% | 3076 |
|
|
2016
Q2 | $1.14M | Buy |
10,704
+5,129
| +92% | +$596K | ﹤0.01% | 3233 |
|
|
2016
Q1 | $638K | Sell |
5,575
-654
| -10% | -$76.7K | ﹤0.01% | 3304 |
|
|
2015
Q4 | $887K | Buy |
+6,229
| New | +$719K | ﹤0.01% | 3232 |
|
State Street's CBPO Position: Q2 2021 in Review
State Street sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 108,451 shares — an estimated $12.8M sold.
State Street first reported a position in CBPO in Q4 2015 and held it in 22 quarters. The position peaked at $12.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- State Street reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- State Street sold 108,451 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $12.8M.
- State Street first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 22 quarters.
- State Street's China Biologic Products Holdings, Inc. position peaked at $12.8M in Q1 2021.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on State Street's 13F filing for Q2 2021, filed 16 Aug 2021.